• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以不明原因肾衰竭、左心室肥厚和反复晕厥为表现的迟发性法布里病:一例报告

Late-onset fabry disease presenting with unexplained renal failure, left ventricular hypertrophy, and recurrent syncope: a case report.

作者信息

Ying Qisu, Yang Xiu, Zhao Ning, Wang Ming, Wu Yu, Shi Xuexue, Shen Jie, Zhao Min, Wang Wenjun, Qian Yingying, Chen Qi, Mao Yong

机构信息

Department of Nephrology, Hangzhou First People's Hospital, Hangzhou, Zhejiang, China.

Department of Nephrology, Hangzhou First People's Hospital Chengbei Campus, Hangzhou Geriatric Hospital, Hangzhou, Zhejiang, China.

出版信息

Orphanet J Rare Dis. 2025 Jun 3;20(1):271. doi: 10.1186/s13023-025-03791-4.

DOI:10.1186/s13023-025-03791-4
PMID:40462218
Abstract

Late-onset cardiac manifestations of Fabry disease are frequently associated with high rates of missed diagnoses and misdiagnoses. We present a case of a 71-year-old male with late-onset Fabry disease whose diagnosis was delayed due to the absence of typical symptoms. The patient has a history of nephrotic syndrome and is currently suffering from end-stage renal disease (ESRD), undergoing maintenance hemodialysis. He was previously diagnosed with diffuse left ventricular hypertrophy and heart block. Upon admission, cardiac examination revealed reduced longitudinal strain of the left ventricle. Fabry disease was suspected due to recurrent heart failure, persistent slight elevation in troponin I (TNI) levels, recurrent syncope, and hearing loss. Subsequent measurement of α-galactosidase A activity and genetic testing confirmed the diagnosis. This case highlights the importance of considering Fabry disease in patients with renal failure, recurrent heart failure, persistent slight elevation in TNI levels, and bilateral interventricular septum syndrome.

摘要

法布里病的迟发性心脏表现常常与高漏诊率和误诊率相关。我们报告一例71岁迟发性法布里病男性患者,其诊断因缺乏典型症状而延迟。该患者有肾病综合征病史,目前患有终末期肾病(ESRD),正在接受维持性血液透析。他此前被诊断为弥漫性左心室肥厚和心脏传导阻滞。入院时,心脏检查显示左心室纵向应变降低。由于反复心力衰竭、肌钙蛋白I(TNI)水平持续轻微升高、反复晕厥和听力丧失,怀疑为法布里病。随后测定α-半乳糖苷酶A活性并进行基因检测确诊。该病例强调了在肾衰竭、反复心力衰竭、TNI水平持续轻微升高和双侧室间隔综合征患者中考虑法布里病的重要性。

相似文献

1
Late-onset fabry disease presenting with unexplained renal failure, left ventricular hypertrophy, and recurrent syncope: a case report.以不明原因肾衰竭、左心室肥厚和反复晕厥为表现的迟发性法布里病:一例报告
Orphanet J Rare Dis. 2025 Jun 3;20(1):271. doi: 10.1186/s13023-025-03791-4.
2
Automated electronic health record-based screening for Fabry disease in unexplained left ventricular hypertrophy (FAPREV-HCM).基于自动电子健康记录的不明原因左心室肥厚患者法布里病筛查(FAPREV-HCM)。
Open Heart. 2025 Jan 11;12(1):e003116. doi: 10.1136/openhrt-2024-003116.
3
Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance.法布里病的不确定诊断:关于左心室肥厚且存在意义不明基因变异的成人患者诊断的共识推荐
Int J Cardiol. 2014 Dec 15;177(2):400-8. doi: 10.1016/j.ijcard.2014.09.001. Epub 2014 Sep 20.
4
Case report: enzyme replacement therapy for Fabry disease presenting with proteinuria and ventricular septal thickening.病例报告:蛋白尿和室间隔增厚的 Fabry 病行酶替代疗法。
BMC Nephrol. 2024 Feb 21;25(1):61. doi: 10.1186/s12882-024-03499-w.
5
Evolution of Cardiac Damage Staged With Echocardiography in Fabry Disease.法布里病中心脏损害的超声心动图分期演变
J Am Heart Assoc. 2025 Jun 3;14(11):e041627. doi: 10.1161/JAHA.124.041627. Epub 2025 May 23.
6
Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope.植入式循环记录仪与不明原因复发性晕厥的传统诊断检查方法对比
Cochrane Database Syst Rev. 2016 Apr 19;4(4):CD011637. doi: 10.1002/14651858.CD011637.pub2.
7
Influence of Treatment Effect Modifiers in Fabry Disease: A Systematic Literature Review.治疗效应修饰因素对法布里病的影响:一项系统文献综述
Adv Ther. 2025 Feb;42(2):579-596. doi: 10.1007/s12325-024-03062-x. Epub 2024 Dec 5.
8
Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: effectiveness of ERT in different disease stages.法布里病的自然病程及酶替代疗法的有效性:一项系统评价和荟萃分析:酶替代疗法在不同疾病阶段的有效性
J Inherit Metab Dis. 2014 May;37(3):341-52. doi: 10.1007/s10545-014-9677-8. Epub 2014 Feb 4.
9
How to escape from sudden death: a challenging case of a rare cardiomyopathy with an unexpected twist.如何逃脱猝死:一例罕见心肌病伴意外转折的挑战性病例
Monaldi Arch Chest Dis. 2025 Jun 19. doi: 10.4081/monaldi.2025.3526.
10
Fabry disease in the haemodialysis population: outcome of a UK screening study (SoFAH).血液透析人群中的法布里病:英国一项筛查研究(SoFAH)的结果
BMC Nephrol. 2025 May 26;26(1):259. doi: 10.1186/s12882-025-04127-x.

本文引用的文献

1
Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week.《法布瑞病的心脏累及:美国心脏病学会杂志每周评论专题》。
J Am Coll Cardiol. 2021 Feb 23;77(7):922-936. doi: 10.1016/j.jacc.2020.12.024.
2
When and How to Diagnose Fabry Disease in Clinical Pratice.何时及如何在临床实践中诊断法布瑞氏病。
Am J Med Sci. 2020 Dec;360(6):641-649. doi: 10.1016/j.amjms.2020.07.011. Epub 2020 Jul 10.
3
Chronic intestinal pseudo-obstruction. Did you search for lysosomal storage diseases?慢性肠道假性梗阻。你是否排查过溶酶体贮积症?
Mol Genet Metab Rep. 2017 Mar 25;11:8-11. doi: 10.1016/j.ymgmr.2017.03.004. eCollection 2017 Jun.
4
Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis.了解法布里病的胃肠道表现:促进早期诊断。
Therap Adv Gastroenterol. 2016 Jul;9(4):626-34. doi: 10.1177/1756283X16642936. Epub 2016 Apr 15.
5
Gastrointestinal involvement in Fabry disease. So important, yet often neglected.法布里病的胃肠道受累。如此重要,却常常被忽视。
Clin Genet. 2016 Jan;89(1):5-9. doi: 10.1111/cge.12673. Epub 2015 Sep 29.
6
Microvascular angina as prehypertrophic presentation of Fabry disease cardiomyopathy.微血管性心绞痛作为法布里病心肌病肥厚前期的表现
Circulation. 2014 Oct 21;130(17):1530-1. doi: 10.1161/CIRCULATIONAHA.114.012178.
7
Fabry's disease.法布里病
J Neurol Sci. 2014 Sep 15;344(1-2):5-19. doi: 10.1016/j.jns.2014.06.029. Epub 2014 Jun 21.
8
High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population.台湾华裔人群新生儿筛查显示法布里病心脏变异型的高发病率。
Circ Cardiovasc Genet. 2009 Oct;2(5):450-6. doi: 10.1161/CIRCGENETICS.109.862920. Epub 2009 Jul 24.
9
A detailed pathologic examination of heart tissue from three older patients with Anderson-Fabry disease on enzyme replacement therapy.对 3 名接受酶替代疗法的老年安德逊-法布里病患者的心脏组织进行详细的病理检查。
Cardiovasc Pathol. 2010 Sep-Oct;19(5):293-301. doi: 10.1016/j.carpath.2009.05.003. Epub 2009 Jul 23.
10
Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A).台湾地区对法布里病进行的新生儿筛查显示,迟发型GLA突变c.936+919G>A(IVS4+919G>A)的发病率很高。
Hum Mutat. 2009 Oct;30(10):1397-405. doi: 10.1002/humu.21074.